Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeiger Counter Regulatory News (GCL)

Share Price Information for Geiger Counter (GCL)

Share Price is delayed by 15 minutes
Get Live Data
72.50    -0.10 (-0.14%)
Bid:
71.00
Ask:
74.00
Spread: 3.00 (4.225%)
Market Cap: £91.21m
GCL Live PriceLast checked at - London Stock Exchange

Intraday Geiger Counter Share Chart

Annual Overview from QuotedData

10 Jul 2025 14:48

RNS Number : 6102Q
Geiger Counter Ltd
10 July 2025
 

Geiger Counter Limited - Annual Overview from QuotedData

10th July 2025

Enriched prospects

A commitment to quadruple nuclear generating capacity in the US, made by President Donald Trump in a series of executive orders signed at the end of May, has provided a significant and much-needed boost to the uranium sector, in which Geiger Counter (GCL) invests. A number of uranium stocks rose by double figures in the days following the pledge to "re-establish the US as a global leader in nuclear energy".

Investor sentiment towards the sector had been waning prior to this, with a number of factors combining to put downward pressure on GCL's net asset value (NAV) (which we explore on page 4). In reality, this was in stark contrast to the fundamentals of the uranium market, which is displaying both demand-side expansion (increasing energy needs, especially from countries seeking lower-emission baseload power) and supply-side constraints. The expertise and long-term track record of GCL's manager, along with the extremely positive market fundamentals, make it an opportune time to invest in the company.

Full Research:

https://quoteddata.com/research/geiger-counter-limited-enriched-prospects-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note Geiger Counter Limited, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEADXEFLKSEFA
Date   Source Headline
2nd Dec 20252:26 pmRNSNet Asset Value(s)
1st Dec 20253:44 pmRNSNet Asset Value(s)
28th Nov 202512:31 pmRNSNet Asset Value(s)
27th Nov 20251:16 pmRNSNet Asset Value(s)
26th Nov 20253:35 pmRNSNet Asset Value(s)
26th Nov 202511:02 amRNSMonthly Factsheet- October 2025
26th Nov 202510:26 amRNSShare BuyBack
25th Nov 202512:34 pmRNSNet Asset Value(s)
24th Nov 20251:56 pmRNSNet Asset Value(s)
21st Nov 20254:06 pmRNSNet Asset Value(s)
20th Nov 20253:44 pmRNSNet Asset Value(s)
19th Nov 20253:55 pmRNSNet Asset Value(s)
19th Nov 202510:34 amRNSShare BuyBack
18th Nov 20253:04 pmRNSNet Asset Value(s)
17th Nov 20253:59 pmRNSNet Asset Value(s)
14th Nov 20254:03 pmRNSNet Asset Value(s)
13th Nov 20252:45 pmRNSNet Asset Value(s)
13th Nov 20259:09 amRNSNet Asset Value(s)
12th Nov 202510:20 amRNSShare buyback
11th Nov 20252:15 pmRNSNet Asset Value(s)
10th Nov 20253:46 pmRNSNet Asset Value(s)
7th Nov 20255:26 pmRNSNet Asset Value(s)
6th Nov 20253:12 pmRNSNet Asset Value(s)
5th Nov 20254:31 pmRNSNet Asset Value(s)
5th Nov 202510:03 amRNSShare BuyBack
4th Nov 20253:09 pmRNSNet Asset Value(s)
4th Nov 20259:16 amRNSNet Asset Value(s)
3rd Nov 20252:50 pmRNSNet Asset Value(s)
31st Oct 20252:43 pmRNSNet Asset Value(s)
30th Oct 20253:12 pmRNSNet Asset Value(s)
29th Oct 20253:35 pmRNSNet Asset Value(s)
28th Oct 20252:33 pmRNSAuditors - Name Change
28th Oct 202512:33 pmRNSNet Asset Value(s)
27th Oct 20253:20 pmRNSNet Asset Value(s)
24th Oct 20252:14 pmRNSNet Asset Value(s)
23rd Oct 20252:26 pmRNSNet Asset Value(s)
22nd Oct 20255:02 pmRNSMonthly Factsheet - September 2025
22nd Oct 20253:18 pmRNSNet Asset Value(s)
22nd Oct 20258:55 amRNSShare BuyBack
21st Oct 202512:56 pmRNSNet Asset Value(s)
20th Oct 20253:15 pmRNSNet Asset Value(s)
17th Oct 20252:39 pmRNSNet Asset Value(s)
16th Oct 20252:49 pmRNSNet Asset Value(s)
15th Oct 20253:58 pmRNSNet Asset Value(s)
15th Oct 20259:49 amRNSShare Buyback
14th Oct 20252:48 pmRNSNet Asset Value(s)
13th Oct 20252:41 pmRNSNet Asset Value(s)
10th Oct 20252:04 pmRNSNet Asset Value(s)
9th Oct 20251:46 pmRNSNet Asset Value(s)
8th Oct 20252:33 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.